Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: Effect on testing rates

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 6, 2003, Pages 679-682

  Jayaraman, Gayatri C ^a,e   Preiksaitis, Jutta K ^b,d   Larke, Bryce ^c,d  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^c Alberta Health and Wellness   (Canada)

^d CANADIAN BLOOD SERVICES   (Canada)

^e HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HEALTH CENTER; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JURISPRUDENCE; MALE; PRENATAL SCREENING;

EID: 0037453078     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Valdiserri RO, Janssen, RS, Buehler JW, Fleming PL. The context of HIV/AIDS surveillance. J Acquir Immune Defic Syndr 2000;25(Suppl 2):S97-104.
2. Bray D. Province wants HIV cases ID'd. Doctors told to reveal patients' names. Edmonton Sun 1998 Feb 10:5.
3. Johnson B. AIDS group OK with tracking HIV patients. Need for reliable statistics cited. Edmonton Sun 1998 Feb 11:16.
4. MacDonald J. Names of sex partners sought to track new HIV cases. Edmonton Journal 1998 Feb 8;Sect A:7.
5. Nakashima AK, Horsely R, Frey RL, Sweeney PA, Weber JT, Fleming PL, et al. Effect of HIV reporting by name on use of HIV testing in publicly funded counseling and testing programs. JAMA 1998;280:1421-6.
6. Hecht FM, Chesney MA, Lehman JS, Osmond D, Vranizan K, Colman S, et al. Does HIV reporting by name deter testing? AIDS 2000;14:1801-8.
7. Woods WJ, Dilley JW, Lihatsh T, Sabatino J, Adler B, Rinaldi J, et al. Name-based reporting of HIV-positive test results as a deterrent to testing. Am J Public Health 1999;89:1097-100.
8. Godin G, Myers T, Lambert J, Calzavara L, Locker D. Understanding the intention of gay and bisexual men to take the HIV antibody test. AIDS Educ Prey 1997;9:31-41.
9. Osmond DH, Bindman AB, Vranizan K, Lehman JS, Hecht FM, Keane D, et al. Name-based surveillance and public health interventions for persons with HIV infection. Multistate Evaluation of Surveillance for HIV Study Group. Ann Intern Med 1999;131:775-9.
10. HIV to become a notifiable disease in Alberta [news release]. Edmonton: Government of Alberta; 1998 Feb 25. Available: www.gov.ab.ca/acn/199802/5914.html (accessed 2003 Feb 12).
11. Robinson JL, Lee BE. Prevention of perinatal transmission of HIV infection. CMAJ 2000;163(7):831-2.
12. Alberta Routine Prenatal HIV Screening Program: final evaluation report prepared for Alberta Medical Association and Alberta Health and Wellness. Edmonton: Howard Research and Instructional Systems; 2001. Available: www.albertadoctors.org/resources/womens/hiv.html (accessed 2003 Feb 12).
13. D'Amelio R, Tuerlings E, Perito O, Biselli R, Natalicchio S, Kingma S. A global review of legislation on HIV/AIDS: the issue of HIV testing. J Acquir Immune Defic Syndr 2001;28:173-9.
14. Division of HIV/AIDS Epidemiology and Surveillance, Centre for Infectious Disease Prevention and Control, Health Canada. HIV injection reporting in Canada. HIV/AIDS Epi Update series. Ottawa: Health Canada; 2002. p. 9-11. Available: www.hc-sc.gc.ca/pphb-dgspsp/publicat/epiu-aepi/hiv-vih/hivrep_e.html (accessed 2003 Feb 12).
15. HIV/AIDS surveillance report. Atlanta: US Centers for Disease Control and Prevention; 2001. Available: www.cdc.gov/hiv/stats/hasrlink.htm (accessed 2003 Feb 12).
16. Stringer EM, Stringer JS, Cliver SP, Goldenberg RL, Goepfert AR. Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates. Obstet Gynecol 2001;98(6):1104-8.
17. Lo B, Wolf S, Sengupta S. Ethical issues to early detection of HIV infection to reduce vertical transmission. J Acquir Immune Defic Syndr Hum Retrovirol 2000;25:S136-43.
18. Simpson WM, Johnstone ED, Goldbert DJ, Gormley SM, Hart GJ. Antenatal HIV testing: assessment of a routine, voluntary approach. BMJ 1999;318:1660-1.
19. Blott M, Yearwood J, Gerval M, Welch J, Zuckerman M. Routine antenatal HIV testing is acceptable to women. BMJ 1999;319:1069-70.
20. Bitnun A, King SM, Arneson C, Read SE. Failure to prevent perinatal HIV infection [letter]. CMAJ 2002;166(7):904-5.
21. Fehrs LJ, Fleming D, Foster LR, McAlister RO, Fox V, Modesitt S, et al. Trial of anonyḿous versus confidential human immunodeficiency virus testing. Lancet 1988;2:379-82.
22. Kegeles SM, Coates TG, Lo B. Mandatory reporting of HIV testing would deter men from being tested [letter]. JAMA 1989;261:1275-6.
23. Hirano D, England B, Hoff C, Helmstadter L, Boyd D, Fickes M, et al. Reporting HIV infections [letter]. J Acquir Immune Defic Syndr 1994;7:417-8.
24. Fordyce EJ, Sambula S, Stoneburner R. Mandatory reporting of human immunodeficiency virus testing would deter blacks and Hispanics from being tested [letter]. JAMA 1989;262:349.
25. Tharao E, Calzavara L, Myers T. To test or not to test: factors influencing HIV testing in east African communities living in Toronto [lecture]. Tenth Annual Canadian Conference on HIV/ADS Research; 2001 May 31-June 3; Toronto.